Source buyout

Buy LabFlow outright, and it stops being for sale.

A buyout hands over the source code of every repository that builds LabFlow's web and Android apps. Once it is paid, LabFlow is not licensed or sold to anyone else, and these pages say so.

What it costslive

Reading the current prices from our licensing service.

What is handed over.

01

The web app

The application, its database schema written as TypeScript with every migration, its server functions, and its build and deploy configuration.

02

The Android app

The native shell built from the same code, with its build configuration. How the store listing moves, if at all, is agreed as part of the sale.

03

Updates for the included months

Counted from the day the sale is paid. Renewal plans stay available after a buyout as well.

The offer.

One price, no discount, and every platform LabFlow ships.

Plus a 7% royalty on LabFlow's gross revenue, paid to us for as long as it earns. The licence terms say how it works.

Reading the current prices from our licensing service.

What changes on the day it is paid.

  • LabFlow is marked as acquired, and every white-label page here stops selling it.
  • Licences sold before the buyout keep their terms, including their updates.
  • The verify page keeps answering for every LabFlow licence.

What a buyout does not include.

Hosting

After the handover the code runs where you choose, and running it is your work.

The team

A buyout transfers code, not people. Work after the included updates is custom work, quoted separately.

Your regulatory approvals

Whoever runs LabFlow for patients needs its own accreditation, registrations and approvals. None of them comes with the code.